PRIMARY CENTRAL NERVOUS SYSTEM (CNS) LYMPHOMA
Clinical trials for PRIMARY CENTRAL NERVOUS SYSTEM (CNS) LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new PRIMARY CENTRAL NERVOUS SYSTEM (CNS) LYMPHOMA trials appear
Sign up with your email to follow new studies for PRIMARY CENTRAL NERVOUS SYSTEM (CNS) LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New cell therapy takes on hard-to-treat brain cancer
Disease control Recruiting nowThis early-phase study tests a new cell therapy called MB-CART19.1 for people with central nervous system lymphoma that has returned or not responded to other treatments. The therapy uses a patient's own immune cells, modified to attack the cancer, and is made on-site. The main g…
Matched conditions: PRIMARY CENTRAL NERVOUS SYSTEM (CNS) LYMPHOMA
Phase: PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 15, 2026 19:08 UTC
-
New cocktail aims to shrink brain tumors
Disease control Recruiting nowThis study tests a combination of five drugs (R-PMDT) in 33 people newly diagnosed with primary central nervous system lymphoma, a rare brain cancer. The goal is to see how many patients' tumors shrink or disappear after six cycles of treatment. Researchers will also track how lo…
Matched conditions: PRIMARY CENTRAL NERVOUS SYSTEM (CNS) LYMPHOMA
Phase: PHASE2 • Sponsor: Zou Dehui • Aim: Disease control
Last updated Jun 11, 2026 12:10 UTC